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ABSTRACT 
Eberhardt, Scott F.  Determining the Effectiveness of the Cancer Phase Training 
Model in a Group Setting.  Unpublished Master of Science, University of 
Northern Colorado, 2017  
 
The role of exercise as a primary therapy has been well documented and has the 
capacity to act across multiple body systems to attenuate cancer-related toxicities.  To 
date, the Cancer Phase Training Model is the only cancer rehabilitation intervention that 
includes recommended modes, intensity, frequency, and duration of exercise for cancer 
survivors.  The one-on-one model has been shown to be the most effective method of 
cancer rehabilitation; however the largest perceived limitation of this model is the 
expense of the program and its lack of scalability.  By creating a structured cancer-
specific group model that can produce similar results to the one-on-one model, we can 
provide a feasible alternative rehabilitation program for cancer survivors.  Purpose: To 
evaluate the effects of the Cancer Phase Training Model in a group setting, on 
cardiorespiratory endurance, muscular strength, and cancer related fatigue in cancer 
survivors.  Methods:  A total of 14 cancer survivors participated in the group model, 
with 12 participants completing the group model.  The frequency of training was 
prescribed as two sessions per week for 12 weeks.  The duration of each exercise session 
was 60 minutes with 20 minutes designated for cardiovascular exercise, 30 minutes for 
resistance exercise, 10 minutes for flexibility training, and with balance exercises 
incorporated throughout the entire session.  Participants in the Group Model had a 
designated time in which they could exercise under the direct supervision of a Cancer 
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Exercise Specialist.  Changes in peak volume of oxygen consumption (VO2peak), 
muscular strength, and Cancer-Related Fatigue were observed once the 12 week 
intervention was completed. Percent change in VO2peak, muscular strength, and fatigue 
from data collected in the Individual Phase Training Model were compared to the data 
collected in the Group Phase Training Model.  Results: After completing a 12-week 
intervention in the Group Model, significant improvements (p<0.05) were observed in 
VO2peak, leg press muscular strength (MS), chest press MS, seated row MS, and shoulder 
press MS, and fatigue.  Although the GM was a pilot study and had a lower number of 
participants, similar results between GM and the IM Phase Training Model were 
observed in all variables.  Participants completing the IM model resulted in an average 
11% increase in VO2peak, while the GM resulted in an average 9% increase. Participant’s 
leg press strength increased by an average of 9% in the IM compared to an average 10% 
increase in the GM.  Participant’s chest press strength increased by an average of 16% in 
the IM, in comparison to an average 16% increase in the GM.   The mean percent change 
in fatigue for participants completing the IM as a 21% decrease, while the GM 
experienced a 36% decrease in fatigue.  Conclusion: This pilot study demonstrates that 
the Phase Training Model protocol can be safely and effectively administrated in a group 
setting.  By offering the Phase Training Program in a group model, healthcare 
professionals can have a greater impact by providing services to more cancer survivors 
without placing the financial burden on the survivor or the program provider. By 
demonstrating its diversity, the Phase Training Model should be considered as a standard 
of care in the clinical cancer rehabilitation setting considering its success in both the 
group and individual model. 
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CHAPTER I 
 
 
INTRODUCTION 
 
There are over 15 million cancer survivors in the United States today, with 
approximately 20 million survivors expected by 2026 (Miller et al., 2016).  This increase 
in survival rate is attributed to improvements in early detection of cancer along with the 
advancement in cancer treatment.  With an increase in survival rate, more cancer 
survivors are suffering from side-effects as a result of radiation, chemotherapy, and 
surgery.  Although cancer treatments are effective in eliminating cancer, they lead to 
debilitating side effects in up to 96% of cancer survivors (Schneider, Dennehy, 
Roozeboom, & Carter, 2002).  The toxicities from cancer treatment have detrimental side 
effects on physiological and psychological aspects of the cancer survivor’s life.   
The negative physiological side effects from treatment affect the cardiovascular, 
immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and musculoskeletal 
systems (Schneider et al., 2002).  The debilitating physiological side effects have a 
significant impact on the negative psychological side effects, which include increased 
fatigue and depression, and a decrease in quality of life (QOL).  The role of exercise as a 
primary therapy has been well documented and has the capacity to act across multiple 
body systems to attenuate cancer related toxicities (Schmitz et al., 2010; Schneider et al., 
2002). Exercise training-induced improvements can be expected regarding aerobic 
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fitness, muscular strength, QOL, and fatigue in survivors with many types of cancer 
(Schmitz et al., 2010).       
 The beginning of cancer rehabilitation can be traced back to the National Cancer 
Act of 1971, which involved a multidisciplinary team of providers, including physiatrists, 
social workers, physical therapists and other medical personnel (Alfano, Ganz, Rowland, 
& Hahn, 2012; DeLisa, 2001).  Today, cancer survivors are spending less time recovering 
in the hospital setting making these multidisciplinary services unnecessary for cancer 
rehabilitation.  Recent research has demonstrated that a one-dimensional approach using 
exercise-based rehabilitation can affect the majority of the disabilities suffered by cancer 
survivors (Schneider, Dennehy, & Carter, 2003).  The American College of Sports 
Medicine (ACSM) suggests that cancer survivors engage in 150 minutes of moderate-
intensity or 75 minutes of vigorous-intensity exercise per week and should avoid 
inactivity.  Adding that prescriptive exercise should be individualized according to a 
cancer’s survivor’s aerobic fitness, medical co-morbidities, response to treatment, and 
negative side effects of treatment that are experienced at any given time (Schmitz et al., 
2010).  To date, the Cancer Phase Training Model introduced by Brown (2016) is the 
only established, structured, individualized model for cancer rehabilitation that includes 
mode, intensity, frequency and duration for cancer survivors throughout the cancer 
continuum.  
Although group and one-on-one model have been reported to be safe and effective 
models for cancer rehabilitation (Dittus et al., 2015; Brown, 2016), current research is 
lacking in providing a consistent structure for a cancer-specific group model.  Research 
shows that there are many benefits for cancer survivors working within a group, 
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including decreasing the financial burden and positively influencing the outcome results 
of a program offered (May et al., 2008, Midtgaard et al., 2005).  The one-on-one model 
has been shown to be the most effective method of cancer rehabilitation; however the 
largest perceived limitation of this model is the expense of the program, not making it 
feasible to offer to the masses.  By creating a structured cancer-specific group model that 
can produce similar results to the one-on-one model, we can provide a feasible alternative 
rehabilitation program for cancer survivors. 
Statement of Purpose 
The purpose of this study was to determine if the UNCCRI Phase Program was 
more effective in a group model setting or in a one-on-one setting.  Effectiveness was 
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and 
cancer-related fatigue. Establishing a cancer rehabilitation model that can be 
administrated in an individual and group setting could provide adaptability for clinics and 
hospitals administrating a cancer rehabilitation program. By creating a structured cancer-
specific group model that can produce results similar to the one-on-one model, a feasible 
rehabilitation program for the large number of cancer survivors could be provided.  It was 
hypothesized that the Cancer Phase Training Rehabilitation Program is more effective 
with a one-on-one model when compared to a group model.   
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CHAPTER II 
 
REVIEW OF LITERATURE 
Introduction 
 Cancer is a disease characterized by the uncontrolled growth and spread of 
abnormal cells, affecting any organ or body part.  This disease is the leading cause of 
death in 22 states and second most common cause of death in the United States (US), 
exceeded only by heart disease, and accounts for nearly 1 of every 4 deaths (Siegel, 
Miller, & Jemal, 2016).  The American Cancer Society (ACS) estimates that over 1.5 
million new cancer cases are expected to be diagnosed in 2016, with nearly 600,000 
people expected to die of cancer in 2016 (Siegel, Miller, & Jemal, 2016).  The most 
common types of cancer are prostate cancer among men and breast cancer among 
women.  Although the 2016 diagnostics number is higher than ever before, cancer 
survival rates continue to increase each year.  The 5-year survival rate for all cancers 
diagnosed during 2005-2011 was 69%, which is up 20% from the 49% survival rate 
during 1975-1977 (Siegel, Miller, & Jemal, 2016). There are over 15.5 million cancer 
survivors in the US today; with 18 million survivors expected by 2022 (Miller et al., 
2016).  This increase in survival rate is attributed to the increase in early detection of 
cancer along with advancements in cancer treatment.   
With an increase in survival rate, more cancer survivors are suffering from 
toxicities as a result from treatments such as radiation, chemotherapy, and surgery.  
Although cancer treatments are effective in eliminating cancer, they lead to debilitating 
5 
 
 
 
side effects in up to 96% of cancer survivors (Schneider et al., 2002).  The toxicities from 
cancer treatment have harsh side effects on physiological and psychological aspects of 
the cancer patient’s life.  The negative physiological side effects from treatment affect the 
cardiovascular, immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and 
musculoskeletal systems (Schneider et al., 2002).   The debilitating physiological side 
effects have a large influence on the psychological side effects, which include increased 
fatigue, increased depression, and a decrease in quality of life (QOL).  Although there are 
specific risks associated with cancer treatment that need to be considered when cancer 
survivors exercise, there is dependable evidence that exercise is safe during and after 
treatment (Schmitz et al., 2010).  Due to this, millions of cancer survivors in the US today 
can benefit from a structured exercise program administered by a trained Cancer Exercise 
Specialist.  As the cancer rehabilitation field continues to grow, hospitals and outpatient 
clinics are beginning to establish different types of exercise interventions including, 
home-based exercise, group-based exercise, and one-on-one-based exercise interventions.  
To date there is only one exercise intervention that is specifically designed with precise 
prescriptive exercise involving all the basic principles of exercise and standardization of 
exercise-based model for cancer patients, which is known as the Cancer Phase Training 
Model (Brown, 2016).   
Cancer Treatments 
The most common treatments for cancer are chemotherapy, radiation, hormonal 
treatment, and surgery.  Alternative treatments involve immunotherapy, hyperthermia and 
stem cell transplant (Siegel, Miller, & Jemal, 2016).  The advancement in cancer 
treatments is one of the crucial contributors to the increased survivorship of cancer 
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patients.  Cancer treatments can be used independently, but are often used in conjunction 
with one another to help increase the chances of treating cancer. 
Chemotherapy is the administration of antitumor drugs that destroy malignant 
tumor cells.  The goal of chemotherapy is to destroy tumor cells and minimize the 
destruction of normal cells while limiting the disruption of normal cell function.  
Chemotherapy is usually administrated orally in pill, capsule, or liquid form, or via vein 
or artery infusion, having an effect on the entire body.  The antineoplastic effects of 
chemotherapy are most pronounced in cells during the proliferation phases of the cell 
cycle.  Because cancer cells proliferate faster than normal cells, chemotherapy drugs 
destroy a higher percentage of cancer cells than normal cells (Schneider, Dennehy, & 
Carter, 2003).  There are different classifications of chemotherapy that attack cancer cells 
differently.  The classes of chemotherapy include alkylating agents, antimetabolites, 
antitumor antibiotics, and alkaloids (Greenhalgh & Symonds, 2014).   
 Radiation therapy uses high-energy X-rays, electron beams, or radioactive 
isotopes to damage and destroy malignant cancer cells (Schneider et al., 2003).  
Unfortunately, like chemotherapy, radiation cannot differentiate between normal cells 
and cancer cells, negatively affecting both cancerous and normal cells that come in 
contact with the radiation.  The response to radiation in normal and cancer cells depends 
on the rate of cell proliferation (Kerr, Winterford, &Harmon, 1994).  The two most 
common types of radiation therapy used are internal and external radiation.  External 
radiation aims beams of radiation from a source outside the body at the targeted tissue 
within the body; while internal radiation places radioactive isotopes near the tumor within 
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the body (Greenhalgh & Symonds, 2014).  The main use of radiation is to target small 
areas of the body and would not be used for metastasizing cancers (Kerr et al., 1994).   
 Surgery can be a safe and effective method of removing cancer in patients with 
solid tumors that are confined to one tissue of organ (Schneider et al., 2003).  Not only 
can surgery be effective in removing cancer but is also used for prevention and diagnosis 
of cancer.  Surgical treatment aims to remove the cancerous tumor cells and some 
surrounding healthy tissue while causing minimal injury to normal functioning of the 
affected area (Schneider et al., 2003).           
Treatment Side Effects 
The adverse effects of cancer treatment may be immediate, resolving during a 
period of days or weeks, or may be persistent, lasting years after the completion of 
treatment (Schmitz et al., 2010).  Treatment side effects are patient-dependent, meaning 
that even though two different patients may have the same diagnosis and treatment, their 
side effects to can differ greatly.  The impact of cancer treatment is not limited to cancer 
cells but also causes deleterious effects on healthy tissues that result in physiological and 
psychological negative side effects in cancer survivors (Schneider, Hsieh, Sprod, Carter 
& Hayward, 2007a).  The side effects from cancer treatment can affect the 
cardiovascular, pulmonary, immune and musculoskeletal systems, which can lead to 
fatigue, depression, and decreased QOL.    
Cardiovascular Toxicities 
Both chemotherapy and radiation therapy have adverse effects on the 
cardiovascular system.  Chemotherapy directly damages cardiac myocytes, resulting in a 
loss of myocardial fibrils, mitochondria changes, and cellular destruction within the 
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cardiac tissue (Camp-Sorrel, 2006).  Chemotherapy-induced cardiovascular toxicities 
may include cardiomyopathy with or without overt congestive heart failure, endothelial 
dysfunction, and arrhythmias (Carver et al., 2007).  Radiation has a large effect on the 
cardiovascular system when external beam radiation is used on the thoracic region.  
Radiotherapy-induced cardiovascular toxicity may include coronary artery disease, 
valvular heart disease, chronic pericardial disease arrhythmias and conduction 
disturbances cardiomyopathy or carotid artery stenosis (Carver et al., 2007).  These 
cardiovascular toxicities can result in left ventricular dysfunction, increased time to peak 
filling of the left ventricle, lower left ventricular ejection fraction, abnormal left 
ventricular contractility, reduced cardiac output and stoke volume, which may lead to 
lower oxygen and nutrient delivery (Schneider et al., 2007a).  The incidence of abnormal 
cardiac function appears to increase with accumulation of time after treatment, and in 
patients with a higher total cumulative dose of chemotherapy and radiotherapy (Carver et 
al., 2007).   
Pulmonary Toxicities 
Cancer patients undergoing cancer treatment may experience acute or chronic 
pulmonary toxicities.  Pulmonary toxicities include radiation pneumonitis, pulmonary 
fibrosis, and an overall decrease in pulmonary function (Carver et al., 2007).  
Chemotherapy causes its initial damage to endothelial cells, causing extensive alterations 
of the pulmonary parenchyma, with changes in the connective tissue, obliteration of 
alveoli, and dilation of air spaces (Camp-Sorrel, 2006).  Radiation destroys the cells 
lining alveoli, and the alveoli become inflamed with accumulated exudative fluid (Camp-
Sorrel, 2006).  Patients may experience coughing, dyspnea, and a low grade fever as a 
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result of pulmonary toxicity (Schneider et al, 2002).  These changes in pulmonary 
function result in shortness of breath, decrease total lung capacity, decrease diffusion 
capacity, which in turn compromises oxygen delivery and carbon dioxide removal 
(Schneider et al., 2007a). These pulmonary toxicities may present as symptoms such as 
fatigue, low exercise tolerance, and restlessness.   
Musculoskeletal Toxicities 
 The side effects from cancer treatment have negative impacts on the muscular 
system, which can be a direct effect of the cancer treatment itself along with other side 
effects from treatment.  Cancer and cancer treatment can induce lean tissue degradation 
and abnormalities in the metabolic system in skeletal muscle, resulting in muscle wasting 
and a decrease in muscular strength in cancer survivors.  This loss in lean muscle occurs 
due to a decline in protein synthesis in conjunction with enhanced protein catabolism 
(Schneider, Hsieh, Sprod, Carter & Hayward, 2007b).  The decrease in protein synthesis 
and protein degradation reduces muscle mass and muscle fiber cross-sectional area, it 
results in the loss of muscle extensibility, and it decreases proteins necessary for 
metabolism. Cancer survivors with reduced protein synthesis and enhanced muscle 
degradation experience muscle weakness, decrease functional work capacity, decreased 
flexibility, and reduced mobility (Schneider et al., 2007b).  Radiation has also been found 
to alter the sarcolemma, sarcoplasmic reticulum, and mitochondrial membrane, leading to 
the disturbances in generating muscle force.  This loss of muscle force is a result of the 
abnormalities in the recycling of calcium (Ca2+) by the sarcoplasmic reticulum and 
abnormalities in the calcium-adenosine triphosphatase (Ca2+-ATPase) system (Schneider 
et al., 2002).  
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Fatigue  
 Fatigue is recognized as the most pervasive and debilitating adverse effect in 
cancer survivors (Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & Morrow, 2007; 
Lawrence, Kupelnick, Miller, Devine, & Lau, 2004).  Cancer-related fatigue (CRF) 
varies greatly from fatigue of everyday life, which is usually temporary and is relieved by 
rest.  The definition of CRF is an overwhelming, draining, whole-body tiredness that is 
unrelated to activity or exertion, and negatively impacts overall well-being and activities 
of daily living, that are not alleviated by rest (Brown 2016).  Hofman et al. (2007) 
reported that 40% of patients at diagnosis, up to 90% of patients treated with radiation 
and 80% of patients treated with chemotherapy experience cancer related fatigue.  
Cardiotoxicity, pulmonary toxicity, musculoskeletal toxicity, and other physiological 
toxicities resulting from treatment may all result in CRF (Schneider & Hayward, 2013).  
Cardiovascular toxicities may reflect a decreased stroke volume and cardiac output, 
which would cause a decrease in oxygen and nutrient delivery to tissues and organs, 
placing more stress on the heart, leading to fatigue.  Pulmonary toxicities have a similar 
effect causing a decrease the amount of oxygen diffusion and lung capacity due to 
pulmonary fibrosis. The decrease in oxygen diffusion also contributes to the decrease in 
oxygen delivery throughout the body.  A decrease in protein synthesis may contribute to 
muscle toxicities, resulting in a decrease in cross-bridge formation and muscle 
contraction, contributing to a decrease in strength and an increase in the sensation of 
fatigue.  Fatigue not only affects physiological systems, it also has a significant impact on 
cancer survivor’s psychological state of mind, including mood, anxiety, and depression 
(Curt et al, 2000).   
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Depression 
 Depression is one of the most common psychological side effects of cancer and 
cancer treatment, affecting 10% to 25% of all cancer survivors (Pirl, 2004).  The most 
common symptoms of depression are negative mood along with low energy, poor 
concentration, loss of interest, memory disturbances, low self-esteem, guilty feeling, 
hypochondriac preoccupation, sleep and appetite disturbances and hopelessness (Pasquini 
& Biondi 2007).  The severity of depression fluctuates depending on the type of cancer, 
the stage of cancer, cancer treatment, and coping strategies of the patient (Schneider et 
al., 2002).  Depression in cancer survivors should be monitored carefully because it can 
affect the patient’s QOL, it can exacerbate inactivity, and it can influence the outcome of 
treatment (Pirl, 2004).    
Quality of Life  
 Quality of life is a term used widely to describe an individual’s assessment of 
their own well-being, including symptoms and functioning in physical, psychological, 
social, and spiritual domains (Hewitt, Greenfield, & Stovall, 2005).  Multiple studies 
have documented that cancer diagnosis and cancer treatments have negative effects on 
patients overall QOL both during and after treatment (Hendren et al., 2012).  These 
effects can be attributed to the cardiovascular, pulmonary and musculoskeletal toxicities 
that result in an inability to complete basic activates of daily living.           
Benefits of Exercise 
Through the advancement in cancer detection and treatment the multidisciplinary 
services of the National Cancer Act of 1971 (Alfano et al., 2012) may no longer be 
necessary for cancer rehabilitation. Resent research has demonstrated that a 
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unidimensional approach using exercise-based rehabilitation can affect the majority of 
the disabilities experienced by cancer survivors.  The role of exercise as a primary 
therapy has been well documented and has the capacity to act across multiple body 
systems to attenuate cancer-related toxicities (Schmitz et al., 2010; Schneider et al., 
2002). 
Although there are specific risks associated with cancer treatment that need to be 
considered when survivors exercise, there is consistent evidence that exercise is safe and 
effective during and after cancer treatment (Schmitz et al., 2010).  Exercise has been 
established as a successful method of rehabilitation for improving both physiological and 
psychological side effects cancer survivors’ experience.  Exercise training-induced 
improvements can be expected in aerobic fitness, muscular strength, QOL, and fatigue in 
many types of cancer survivors (Schmitz et al., 2010).   
When analyzing the effects of exercise on cancer toxicities, cardiovascular and 
pulmonary toxicities are usually group into one category, cardiorespiratory.  Acute and 
chronic exercise can enhance the cardiorespiratory system. The physiological changes 
that occur through exercise reduces stress on the heart and blood vessels, thus enhancing 
the ability of the heart and lungs to more efficiently deliver oxygen to the working tissues 
(Schneider et al., 2002). These changes improve cardiovascular efficiency, increase 
cardiac output and stroke volume, decrease resting heart rate, lower exercise heart rate 
and improve ventilation and transport of oxygen (Schneider et al., 2007a).  Improvements 
in the pulmonary system include an increase in forced vital capacity, forced expiratory 
volume, predicted maximal oxygen consumption, and the length of time on the treadmill 
(Schneider et al., 2007a).  These benefits of exercise have the potential to reverse or 
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attenuate the cardiorespiratory toxicities experienced by cancer patients. Research 
indicates that relatively short-term, structured, moderate-intensity exercise training 
significantly improves VO2peak in cancer patients both during and following adjuvant 
therapy (Jones et al., 2011).  
Exercise improves the efficiency of skeletal muscle cells to preform contractions, 
alleviating the effects of muscle wasting and decreased strength experienced by cancer 
patients (Schneider et al., 2003).  The changes occur through an increase in the number 
and size of mitochondria, increased ability to resynthesize adenosine triphosphate (ATP), 
increased myoglobin, increased protein synthesis, and increased muscle fiber cross-
sectional area (Schneider et al., 2007a).  
The positive physiological outcomes from a proper exercise intervention have a 
large effect on increasing patient’s psychological variables including fatigue, depression 
and QOL.  Regular physical exercise improves mood, body image, self-concept, and 
sleep patterns, resulting in decreased anxiety, depression and feeling of helplessness in 
cancer patients (Schneider et al., 2003).  Research indicates that cancer patients 
participating in a supervised exercise intervention have significantly reduced levels of 
fatigue when compared to a control group (Carayol et al., 2013; Puetz & Herring, 2012) 
with one study reporting 32-39% decreases in fatigue scores (Schneider, & Hayward, 
2013).  With a strong correlation between fatigue and depression severity, improvements 
can also be seen in depression following an exercise intervention.  Patients who exercise 
during treatment can experience a 43% decrease in depression, while participants 
exercising following treatment report a 25% decrease. With an increase in physiological 
variables along with a decrease in fatigue and depression, QOL significantly increases. 
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Blanchard et al. (2003) reported that promoting exercise three days per week is suggested 
in order to experience optimal increases in QOL.   
Physical Activity vs. Prescribed Exercise 
Research indicates that physical activity or an exercise intervention can positively 
affect the physiological and psychological side effects of cancer treatment and inactivity 
should be avoided (Schmitz et al., 2010).  When reviewing the exercise programs created 
for cancer patients, programs should be split up into physical activity and prescriptive 
exercise.  Physical activity is defined as any body movement produced by skeletal 
muscles that requires more energy expenditure than resting (Caspersen, Powell, & 
Christenson, 1985), such as walking, running, swimming, yoga and gardening.  The 
American College of Sports Medicine (ACSM) suggest that cancer survivors engage in 
150 minutes of moderate-intensity or 75 minutes of vigorous-intensity exercise per week 
(Schmitz et al., 2010).  However, these guidelines are very broad and fall within the 
definition of physical activity.  ACSM added that prescriptive exercise should be 
individualized according to a cancer survivor’s aerobic fitness, medical comorbidities, 
response to treatment, and negative side effects of treatment that are experienced at any 
given time (Schmitz et al., 2010).  These considerations emphasize the need for 
prescriptive exercise interventions when working with cancer patients.  Prescriptive 
exercise refers to specific exercise guidelines prescribed for an individual that are 
designed for a specific purpose or purposes.   
If one is to expect specific outcomes from therapeutic exercise interventions, it is 
necessary to prescribe exercise using the fundamental principles of exercise such as 
specificity, progression, overload, initial values, reversibility and diminishing returns 
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(Winter-Stone, Neil, & Campbell, 2013).  When comparing different types of exercise 
interventions designed for cancer patients, it is very important that programs follow these 
principles to take into account the cancer patients physiological and psychological 
alterations during and after treatment.  The most popular exercise interventions for cancer 
patients include home-based interventions, group interventions, and individual one-on-
one interventions (Blaney et al., 2010).  Unfortunately, there are only a hand-full of 
exercise models that address the majority of the principles of exercise.  Of the hand full 
of exercise interventions, all but one lacks the appropriate assessment, prescription, and 
interventions needed to directly target the toxicities caused by cancer treatments.  Home-
based exercise interventions for cancer patients often recommend modes of physical 
activity such as walking or yoga, and do not fall within the principles of exercise.  
Although home-based exercise interventions may have positive effects on the 
physiological and psychological aspects of a cancer survivor’s life, not adhering to the 
principles of exercise does not make it a valid unidimensional mode of cancer 
rehabilitation.   The only possible way to properly administer a prescriptive exercise 
intervention is under the supervision of a Cancer Exercise Specialist (CES) in either a 
group or individual setting.  With the increasing number of possible exercise 
interventions available, it is important to determine whether a group or individual model 
is more effective when administering a rehabilitation program in a hospital or outpatient 
setting.                  
In the apparently healthy population, group exercise means having one exercise 
professional leading a group through a series of exercises performed all together 
throughout a session.  The group class is not specifically designed for every individual in 
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the group but focuses on increasing general physiological aspects of fitness.  Most group 
classes are held at certain times and participation is not mandatory.   However, the term 
“group” has a different meaning in exercise-based cancer rehabilitation when compared 
to the general public’s view of group exercise.  A group-based cancer rehabilitation 
intervention is classified as two or more participants that are able to attend a reserved 
time in a facility where cancer patients can come in and complete a specifically designed 
individual workout under supervision of an exercise professional or physical therapist.  
Not only do cancer survivors have an individual workout but frequency, intensity and 
time are all prescribed in each workout.  Cancer group exercise is also a prescribed 
amount of time to complete the program.  After a cancer survivor has completed their 
program they will be re-tested and prescribed a new exercise regimen with new 
frequencies, intensities, and time, based on their assessment results.  During the allotted 
time for group exercise cancer survivors are encouraged to complete as many exercises as 
possible during their allotted time.    
 The group-based cancer rehabilitation intervention has been a popular model in 
many hospitals and clinics.  While both group and one-on-one exercise interventions 
have been established as safe and effective for cancer patients, there are many benefits 
that come from working within a group.  Not only can a group model decrease the 
financial burden on cancer survivors, it may also result in positive program outcomes 
(May et al 2008, Midtgaard et al, 2005).  Braney et al. (2010) conducted a qualitative 
study illustrating that most participants would prefer exercising with other patients with 
cancer within a clinic or hospital setting, as they would have similar cancer experiences 
and comparable fitness levels.  
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The University of Vermont recently published parameters for a group-based 
cancer rehabilitation intervention that is based off a cardiac rehabilitation model. Dittus et 
al. (2015) proposed a three phase program that separates cancer survivors whether they 
are in or out of treatment and the time in which they have completed cancer treatment.  
Phase 1 addresses range of motion defects and deconditioning after surgery while 
receiving cancer treatment, working one-on-one with a physical therapist transitioning to 
independent exercise.  Phase 2 consisted of structured group, medically supervised 
exercise immediately after cancer treatment, addressing persistent side effects and 
deficits, supervised exercise progression, and lifestyle improvements. Phase 3 was 
characterized as independent group exercise to improve fitness and lifestyle interventions 
to improve chronic disease management.  In this study the only phase that can be 
classified as cancer rehabilitation group exercise is Phase 2.  In this phase patients are 
prescribed specific frequency, intensity and time, based off of the cancer survivor’s 
fitness assessment.  Phase One of this program is working with a physical therapist to 
make sure the survivor has normal range of motion, while Phase 3 in this study is 
classified as apparently healthy group exercise, neither Phase 1 or Three incorporate the 
principles of exercise.  Phase 2 of this program was a cancer rehabilitation group design 
with individuals exercising in a less supervised fashion, with an exercise physiologist 
available if needed.  The group intervention for Phase 2 consisted of two days a week of 
aerobic and resistance training.  The training program included twenty minutes of aerobic 
training at 70%-80% peak heart rate or between a RPE of twelve and fourteen.  The 
resistance training included upper and lower extremity exercises with the intensity set at 
60%-70% of one repetition maximum or able to complete eight repetitions with good 
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form.  Data collected from Phase two throughout the 12 week program showed an 8% 
increase in VO2peak, 22% increase in chest press one rep max, 22% increase in  leg press 
one rep max, 36% decrease in fatigue, 25% decrease in depression and 19% decrease in 
anxiety (Dittus et al. 2015). Throughout their prescriptive exercise they adhered to all 
principles of exercise.  The limitations of this program are the methods used to obtain 
baseline results and that the design of the program was developed for cardiac patients 
rather than cancer survivors.  However, this program illustrated that group-based cancer 
rehabilitation is safe for cancer patients to perform and has positive effects on the 
physiological and psychological side effects of cancer treatment. 
In contrast, the University of Northern Colorado Cancer Rehabilitation Institute 
(UNCCRI) created the first individual one-on-one model designed specifically for cancer 
survivors (Schneider et al., 2002).  This model utilizes a four phase program that is 
classified by what point on the cancer continuum the cancer survivor falls in.  Phase 1 
individuals are classified as patients currently in treatment (chemotherapy and/or 
radiation).  Phase 2 individuals are patients who have never received chemotherapy or 
radiation, who have completed chemotherapy or radiation treatment, or have completed 
Phase 1.  Phase 3 are patients who have completed phase two, and phase four are patients 
completed with phase three. The Cancer Phase Training Model uses cancer-specific 
physiological and psychological assessments to create specific, individualized 
prescriptive exercise interventions.  Each Phase has different exercise intensities and 
goals that are based off of the initial assessment of each participant.  Phase 1 intensities 
may be classified as low, ranging between 30-45% heart rate reserve (HRR) and 
estimated one repetition maximum (EST 1-RM).  Phase 2 intensities may be classified as 
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low to moderate ranging 40-60% HRR and EST 1-RM.  Phase 3 intensities may be 
classified as moderate to high and range between 60-85% HRR and EST 1-RM.  The 
frequency of training was prescribed as three sessions per week for twelve weeks. The 
duration of each exercise session was sixty minutes with twenty minutes designated for 
cardiovascular exercise, thirty minutes for resistance exercise, ten minutes for flexibility 
training, and with balance exercises incorporated throughout the entire session. From the 
data collected, Phase 1 participant’s results showed a 13% increase in VO2peak, 8% 
increase in leg press one rep max, 16% increase in chest press one rep max, and a 27% 
decrease in fatigue.  Phase 2 participants results showed a 15% increase in VO2peak, 16% 
increase in leg press one rep max, 23% increase in chest press one rep max, and 27% 
decrease in fatigue.  Phase 3 participants results showed a 5% increases in VO2peak, 4% 
increase in leg press one rep max, 8% increase in chest press one rep max, and a 8% 
decrease in fatigue (Brown, 2016).  As previously mentioned this is the first exercise 
program that included all the basic principles of exercise and cancer specific assessments 
to properly prescribe a therapeutic exercise intervention tailored specifically for cancer 
patients.   
The purpose of this study was to determine if the UNCCRI Phase Program was 
more effective in a group model setting or in a one-on-one setting.  Effectiveness was 
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and 
cancer-related fatigue. Establishing a cancer rehabilitation model that can be 
administrated in an individual and group setting could provide adaptability for clinics and 
hospitals administrating a cancer rehabilitation program. By creating a structured cancer-
specific group model that can produce results similar to the one-on-one model, a feasible 
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rehabilitation program for the large number of cancer survivors could be provided.  It was 
hypothesized that the Cancer Phase Training Cancer Rehabilitation Program is more 
effective with a one-on-one model when compared to a group model.   
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CHAPTER III 
 
METHODOLOGY 
 
Participants 
 Data were obtained from subjects participating in the Cancer Phase Training 
Group Model (GM) from during the 2016 calendar year.  All participants were eligible 
for participating in the group study if they were cleared to participate in an exercise 
program through a referral by his/her oncologist or primary care physician.  Participants 
had to be able to move freely around the facility with minimal assistance and did not 
require spotting while walking.  Participants that required a walker to move around the 
facility were excluded from the group study.  
Participants were both male and female cancer survivors who were currently 
undergoing or had completed cancer treatment including surgical intervention, 
chemotherapy, radiation therapy, immunotherapy, hormonal therapy, and/or other types 
of unconventional treatment.  Safety of the participants was ensured throughout all data 
collection, exercise testing, and exercise training through supervision by a CES.  Along 
with the referral from the physician or oncologist, a detailed medical and cancer history 
of each participant was provided.  Prior to any data collection, all participants were 
informed that they were volunteers and could terminate their involvement in the study at 
any time.  Subjects entered into the program with a rolling enrolment, meaning they 
could start their twelve week program once they signed up and did not have to wait for a 
specific start date.  After a thorough explanation of the group program, each participant 
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agreed to participate and signed an informed consent.  All protocols used for the study 
were approved by the University of Norther Colorado’s (UNC) Institutional Review 
board (Appendix A).  All exercise testing and training took place at UNCCRI on the 
University of Northern Colorado campus in Greeley, Colorado. 
Recruitment 
Participants were recruited into the group study from cancer patients that were 
referred by their oncologist or primary care physician to participate in an exercise 
intervention at UNCCRI.  Participants were notified about the GM in the initial call from 
UNCCRI after receiving their referral to schedule their initial assessment.  One incentive 
of a subject to participate in the GM was that the price for a twelve week intervention 
was reduced compared to participating in the individual protocol.  Another incentive for 
subjects was that they would be exercising with other cancer survivors that they could 
socialize with throughout the program.  The GM was only offered at UNCCRI on 
Tuesday and Thursday at 8 am and 11 am.  Once a participant signed up for the group 
model they were asked to pick either of the designated times to attend throughout the 12-
week program.  If participants had a scheduling conflict for treatments or medical 
appointments they were given the opportunity to attend an alternate time during those 
days.  One limitation to the GM was the schedule was that the times offered had to fit 
within the participants’ schedule in order to participate in the GM.             
Patient Screening and Paperwork 
 After receiving the participant’s physician referral and signed consent form, each 
subject was asked to complete questionnaires evaluating their psychological function, 
lifestyle, behavior, and medical information.  All questionnaires were completed at the 
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subject’s home prior to their initial assessment.  The questionnaires included: Medical 
History, Revised Piper Fatigue Scale, Beck Depression Inventory questionnaire, and 
Ferrans and Powers Quality of Life Index Version III.   
Medical History  
Participants’ medical information was obtained via this self-reported worksheet 
detailing present medical history, family medical history, medications, allergies, and 
cancer diagnosis.  If needed, further medical information was requested from the 
participants’ oncologist or primary care physician.  
Revised Piper Fatigue Scale  
Fatigue was measured via the Piper Fatigue Inventory, which evaluates total 
cancer-related fatigue, as well as four subscales of fatigue: behavior/severity, affective 
meaning, sensory, and cognitive/mood.  These individual subscales comprise 22 
questions to help calculate each subscale and a score representing total fatigue.  In order 
to calculate fatigue on each subscale the sum of each subscale is taken and divided by the 
number of items on that subscale.  To calculate the total fatigue, all twenty questions 
were added together and divided by twenty two.  The fatigue scale ranges from zero to 
ten, a score of zero indicates that the participant shows no sign of fatigue, a score from 
one to three indicates mild fatigue, four to six indicates moderate fatigue, and a score 
greater than or equal to seven indicates severe fatigue (Piper et al, 1998).  
Beck Depression Inventory  
This questionnaire is a valid and reliable (Vodermaier, Linden, & Siu, 2009) 21-
question index that assessed symptoms such as, but not limited to hopelessness, feelings 
of being punished, weight loss, and guilt.  Each question is rated on a four point scale 
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ranging from zero to three based on the severity of each item.  The sum all the rated 
questions are taken to determine the individual’s depression, with a maximum total score 
of 63.  The higher the score indicate more severe depression with 0 indicating no 
depression and >40 indicating extreme depression.  
Ferrans and Powers Quality of Life Index Version III  
This 66-question questionnaire is designed to evaluate social, psychological, 
family and health satisfaction as well as total QOL. Higher scores indicate greater 
satisfaction in QOL (Ferrans & Powers, 1985).  
Prior to the initial assessment and each subsequent reassessment, a detailed 
medical and cancer screening was recorded on the Client Summary form. The Client 
Summary listed all pertinent cancer information, including type, stage and diagnosis date, 
cancer treatments received or currently receiving, additional medications concerns that 
may affect training, disease concerns, including family health history, current 
medications, current and past physical activity level, and short and long term goals. 
Assessment Protocols 
Prior to the design of the participants’ prescriptive exercise, each participant 
completed an Initial Assessment.  Each assessment measured vitals, body composition, 
cardiovascular endurance, muscular strength, and flexibility and range of motion (ROM).  
Results from the assessment were recorded on the Data Collection Sheet for the 
corresponding Phase. Reassessment occurred after each twelve week exercise 
intervention completed by the participant.  
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Vital Measurements 
 Prior to and following the completion of exercise testing, participants’ heart rate 
(HR), oxygen saturation (SpO2), and blood pressure (BP) were assessed via heart rate 
monitors around the chest, pulse oximeter, and sphygmomanometer and stethoscope, 
respectively. 
Body Composition 
 Body fat percentage was first assessed via the three-site skinfold (SKF) test using 
a Lange skin fold caliper. The three-site SKF locations for men were: the chest, abdomen, 
and thigh. The three-site SKF locations for women were: the triceps, suprailiac, and 
thigh. Two measurements, in a rotational order, were taken; a third was taken at any site 
that differed by more than two millimeters. Waist-to-hip ratios were measured in inches 
using a tape measure at the slimmest point on their waist and the widest point on their 
hip.  
Cardiovascular Endurance 
 Cardiovascular endurance was evaluated using the cancer-specific UNCCRI 
Treadmill Protocol, which yields VO2peak values. This protocol was found to be the most 
accurate and appropriate for the cancer population (Shackelford, Brown, Peterson, 
Schaffer, & Hayward, 2015). The goal of this test was for the participant to reach self-
perceived maximal exertion or fatigue. The highest measurement of oxygen consumption 
was calculated. This protocol consists of one minute stages, which increased speed and/or 
incline at the conclusion of every stage. During the test, HR and SpO2 were collected at 
the end of every minute. BP was recorded at the end of every three minutes, as well as the 
participant’s rating of perceived exertion (RPE) on the modified Borg Scale. This RPE 
26 
 
 
 
scale consisted of numbers zero to ten which correlates to the participants’ perceived 
intensity of the test. An RPE of zero correlates with the intensity of a stroll in the park, 
and a RPE of ten signifies the patient has reached his or her maximal effort and cannot 
continue. The use of handrails was discouraged, but was allowed if deemed necessary.  If 
necessary, handrail usage was required throughout the entire test in order to stay 
consistent. Termination criteria of the test were: participant reached volitional fatigue or 
asked to stop for any reason, failure to increase systolic BP or HR with increased 
intensity, fluctuation of more than 10 mmHg from resting measures in diastolic BP, or 
oxygen saturation drops below 80 on the pulse oximeter. Once the testing ended, each 
subject completed a cool-down period, where all of the aforementioned variables were 
measured in the same manner as during the test. Final treadmill time, BP, HR, and RPE 
was recorded. Peak volume of oxygen consumption was estimated using ACSM’s 
walking and running equations, which have been found to be valid in determining 
VO2peak (Shackelford et al., 2015). 
Muscular Strength Assessment 
 Muscular strength was assessed via the estimated 1-repetition maximum protocol 
(EST 1-RM) using the Brzycki equation. This test used Cybex Eagle resistance machines 
(Cybex Inc., Medway, MA), and specifically utilized the following machines: chest press, 
lat pulldown, seated row, shoulder press, leg press, leg curl, and leg extension. The goal 
of this test was to have the participant lift as much weight as possible between one and 
ten repetitions. RPE values were asked at the end of every set. The test was performed in 
six steps as follows: (1) before the participant began the test, the CES demonstrated how 
to perform each machine correctly with proper form, and adjusted the machine to ensure 
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a proper fit for each participant. (2) The participant was then asked to perform a warm-up 
set, which consisted of five repetitions at a low intensity. (3) After the warm-up set, the 
weight was increased accordingly to elicit muscular failure or fatigue between 1 and 10 
repetitions. (4) The participant then attempted to lift the weight deemed appropriate to 
elicit failure between one to ten repetitions. (5) If the weight appeared to be too light to 
elicit failure between one to ten repetitions, the set was stopped immediately and the 
weight increased. If the weight was too heavy for even one full repetition, the weight was 
reduced accordingly. (6) After a two to three minute rest, steps four and five may have 
been repeated up to two times per machine to elicit a weight that resulted in muscular 
fatigue between one and ten reps. The EST 1-RM values, as pounds (pounds) lifted, were 
recorded for each machine.   
Flexibility and Range of Motion Assessment 
The modified sit-and-reach (SR) test, back scratch test, and reaching tests were 
used to assess flexibility and range of motion. For the modified SR test, the participant 
was instructed to sit on the floor with his or her shoulders, head, and hips against a wall. 
The legs were extended in front of them, with their feet flat against a twelve inch SR box. 
The participant then extended his or her arms out, with one on top of the other. The end 
of the arm of the SR box was positioned so it was at the end of the participant’s 
fingertips. The participant was instructed to bend forward at the hips and slide the 
fingertips along the arm of the SR box until no further extension was possible. The value 
was recorded in inches. This procedure was conducted two additional times, and the 
highest value recorded.  
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The back scratch test required the patient to reach up and behind their back with 
the dominant hand, palm facing the back. They were asked to reach the other arm down 
and behind the back as far as possible, with the palm facing away from the back. Both 
wrists were kept as straight as possible. The distance between each middle finger was 
used as landmarks and the distance in inches recorded. If the fingertips touched without 
overlapping, the score was recorded as zero inches. If they did not touch, the score was 
recorded as a negative value in centimeters, and if they overlapped it was recorded as a 
positive value in centimeters.  
For the reaching tests, the participant was asked to reach as far as possible with 
both arms in the anterior plane, and then the sagittal plane. Arms were kept as straight as 
possible. The highest score in each plane (anterior: 1 to 4; sagittal: 1 to 8) was recorded.  
Phase Training Model: Prescriptive Exercise 
Prescriptive exercise took place following the assessment and was created using 
the Client Overview document.  The Client Overview indicated the starting Phase, and 
starting target intensity of both the aerobic and resistance training components of the 
program. The participant screening, which was recorded on the Client Summary, and the 
data collected from each assessment protocol, which was recorded on the Data Collection 
Sheet, were used together to create the prescriptive exercise for each participant.  If the 
subject was currently undergoing chemotherapy and/or radiation therapy, he or she was 
placed in Phase I. If treatment had ended at entry into the program or if the subject 
underwent surgical intervention and/or other treatments (hormonal, immune, etc.), he or 
she was placed in Phase II. The assessment results and specifically the classifications 
achieved by the participant during each assessment were utilized to begin the process of 
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selecting the appropriate target intensity of the intervention. The Client Summary further 
assisted the prescription of intensity as the principles of individualization and specificity 
were utilized in relation to each patient’s specific goals and desired outcomes from the 
program.    
Exercise Intervention 
All exercise sessions were completed at UNCCRI under supervision of a CES.  
There was one CES working with the group throughout its duration, who recorded all 
physiological data.  In the healthy population, group exercise means having one exercise 
professional leading a group through a series of exercises performed all together 
throughout a session.  The group class is not specifically designed for every individual in 
the group but focuses on increasing general physiological aspects of fitness.  However, 
the term “group” has a different meaning in exercise-based cancer rehabilitation when 
compared to the general public’s view of group exercise.  A group-based cancer 
rehabilitation intervention is classified as two or more participants that are able to attend 
a reserved time in a facility where cancer patients can come in and complete a 
specifically designed individual workout under supervision of an exercise professional or 
physical therapist.  The beginning of a group-based intervention includes an orientation, 
where participants are introduced to the exercises and proper use of the equipment for the 
first week.  Once the intervention begins the exercise professional takes more of a 
supervising role only helping to increase intensity and assist if there are any questions. 
Cancer survivors are encouraged to complete as many exercises as possible during their 
allotted time.    
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The frequency of training was prescribed as two sessions per week for twelve 
weeks.  The duration of each exercise session was sixty minutes with twenty minutes 
designated for cardiovascular exercise, thirty minutes for resistance exercise, ten minutes 
for flexibility training, and with balance exercises incorporated throughout the entire 
session.  Participants used the following modes for the aerobic portion of the exercise 
session; treadmill, recumbent cycle ergometer, upright cycle ergometer and NuStep.  For 
the resistance training, each session focused on a full body workout targeting all the 
major muscle groups including, chest, back, lower body, and core, and utilized three sets 
of ten repetitions for each exercise.  By participating in the group model the majority of 
all the resistance training was performed on Cybex resistance machines, additional 
exercises were prescribed to each participant individually which included Thera band, 
dumbbells, body weight, and resistance tubing.  The flexibility portion used straps, 
chairs, and steps to help focus on targeting all major muscle groups that were used during 
the exercise session.     
The intensity of the prescriptive exercise was directly based off of the individual’s 
treatment status, assessment results and the starting Phase.  Participants who were still in 
treatment would enter the phase program in Phase I.  The goal of Phase I was to maintain 
or slightly increase the participant’s physiological and psychological values.  Participants, 
who have completed chemotherapy or radiation, or who had never received either of 
these treatments, were prescribed to Phase II.  Phase II is also the next Phase for 
participants who have completed Phase I.  Participants enter into Phase III only by 
completing Phase II.   
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The GM did not use heart rate monitors to record intensity during the aerobic 
session, due to only having one CES accounting for multiple participants.  Instead the 
revised RPE scale (0-10) was used to prescribe intensity for the aerobic portion.  The 
starting intensity for Phase I was low, ranging between 30-45% EST 1-RM and an RPE 
of 4-6. Phase 2 starting intensity was low to moderate, ranging between 40-60% EST 1-
RM and a RPE of 5-7. The starting intensity for Phase 3 was moderate to high, with 
intensities ranging between 60-85% EST 1-RM and a RPE of 6-8. Phase 4 starting 
intensity was moderate to near maximal, ranging between 65-95% EST 1-RM and a RPE 
of 6-9.  To ensure the principles of progression and overload were met throughout each 
phase, participants were educated about these two key factors of the intervention and 
were taught how to apply them to their intervention.  Through this education, participants 
were given the freedom to increase their weight and aerobic intensities and report back to 
the CES to record the increases.  If the CES did not receive self-reported increases from a 
participant after three weeks of new intensities for their strength or aerobic training, the 
CES would encourage the participant to increase their weight on the strength machines or 
the speed or grade on the aerobic equipment.       
Exercise Intervention Orientation 
The first two days of the GM, survivors participated in an orientation of their 
exercise program.  Lacking the direct supervision of a CES for each participant, the main 
goal of orientation was to understand the intensity and progression of their intervention as 
well as the proper use and safety precautions of all equipment being used.   
Day One Orientation: The first part of day one of the orientation had the 
participant and Cancer Exercise Specialist review initial results along with the intensity in 
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which the Cancer Exercise Specialist has prescribed for the participant. The 
understanding of RPE scale was explained to make sure the participant had a clear 
understanding for both cardiovascular RPE and muscular strength RPE.  Progressive 
overload was explained to the participant to make sure progress is accomplished 
throughout the twelve weeks.  Participants were given the freedom to increase their 
weight throughout the twelve weeks; if the CES did not see any progress the CES would 
suggest an increase in intensity in either cardiovascular endurance or muscle strength. 
The second part of orientation consisted of machine orientation of the cardiovascular 
equipment.  During this time the participant was shown all the available options to 
perform the cardiovascular aspect of the workout.  How to properly get on and off the 
machine, changing intensity and how to stop the machine immediately in case of an 
emergency was reviewed.     
Day Two Orientation: Day two consisted of a review of the cardiovascular 
machines, as well as the muscular strength machine orientation.  During the machine 
orientation participants were shown how to properly use each piece of machine along 
with the proper seat position on every machine.  During this time, participants were able 
to go over their prescribed weights on each machine and report to the CES if they felt like 
it was an accomplishable weight to begin with.  If participants were not able to safely 
complete the prescribed weight the CES was able to make adjustments to determine the 
appropriate starting weight. After completion of the two days of orientation, the 
participant began their twelve week intervention.         
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Statistical Analysis 
  
 Two related samples Wilcoxon Signed-Rank Test was utilized to examine if 
significant differences occurred in cardiovascular endurance, muscular strength, and 
fatigue.  The following dependent variables were assessed: VO2peak, EST 1-RM of leg 
press, EST 1-RM chest press, EST 1-RM seated row, EST 1-RM lat pull down, EST 1-
RM shoulder press and fatigue.  With the low number of participants, pre and post results 
of all completed phases were compared.  Statistical analyses were performed using the 
Statistical Package for the Social Science software package (SPSS, Chicago, IL).  
Significance levels were set at p < 0.05.    
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Introduction 
 There are over 15.5 million cancer survivors in the United States today; with 20 
million survivors expected by 2026 (Miller et al., 2016).  This increase in survival rate is 
contributed to the increase in early detection of cancer along with the advancement in 
cancer treatment.  With an increase in survival rate, more cancer survivors are suffering 
from toxicities as a result of radiation, chemotherapy, and surgery.  Although cancer 
treatments are effective in eliminating cancer, they lead to debilitating side effects in up 
to 96% of cancer survivors (Schneider, Dennehy, Roozeboom, & Carter, 2002).  The 
toxicities from cancer treatment have detrimental side effects on physiological and 
psychological aspects of the cancer survivor’s life.   
The negative physiological side effects from treatment affect the cardiovascular, 
immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and musculoskeletal 
systems (Schneider et al., 2002).  The debilitating physiological side effects have a large 
influence on the negative psychological side effects, which include increased fatigue and 
depression, and a decrease in quality of life (QOL).  The role of exercise interventions as 
a primary therapy has been well documented and has the capacity to act across multiple 
body systems to attenuate cancer related toxicities (Schmitz et al., 2010; Schneider et al., 
2002). Exercise training-induced improvements can be expected regarding aerobic 
fitness, muscular strength, QOL, and fatigue in many types of cancer survivors (Schmitz 
et al., 2010).       
 The beginning of cancer rehabilitation can be traced back to the National Cancer 
Act of 1971, which involved a multidisciplinary team of providers, including physiatrists, 
social workers, physical therapists and other medical personnel (Alfano, Ganz, Rowland, 
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& Hahn, 2012; DeLisa, 2001).  Through the advancement in cancer detection and 
treatment, cancer survivors are spending less time recovering in the hospital setting 
making these multidisciplinary services unnecessary for cancer rehabilitation.  Recent 
research has demonstrated that a one-dimensional approach using exercise-based 
rehabilitation can affect the majority of the disabilities suffered by cancer survivors 
(Schneider, Dennehy, & Carter, 2003).  The American College of Sports Medicine 
(ACSM) suggests that cancer survivors engage in 150 minutes of moderate-intensity or 
75 minutes of vigorous-intensity exercise per week and should avoid inactivity.  Adding 
that prescriptive exercise should be individualized according to a cancer’s survivor’s 
aerobic fitness, medical co-morbidities, response to treatment, and negative side effects 
of treatment that are experienced at any given time (Schmitz et al., 2010). To date, the 
Cancer Phase Training Model introduced by Brown (2016) is the only established 
structured individualized model for cancer rehabilitation that includes mode, intensity, 
frequency and duration for cancer survivors throughout the cancer continuum.  
Although the group and one-on-one model have been established as safe and 
effective models for cancer rehabilitation (Dittus et al., 2015; Brown, 2016), to date 
research is lacking in providing a consistent structure for cancer specific group model.  
Research shows that there are many benefits for cancer survivors working within a group, 
including decreasing the financial burden on cancer survivors and positively influencing 
the outcome results of a program offered (May et al., 2008, Midtgaard et al., 2005). The 
one-on-one model has been proven to be the most effective method of cancer 
rehabilitation; however the largest perceived limitation of this model is the expense of the 
program, not making it feasible to offer to the masses.  The purpose of this pilot study is 
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to evaluate the effects of the Cancer Phase Training Model in a group setting, on 
cardiorespiratory endurance, muscular strength, and cancer related fatigue in cancer 
survivors.  By creating a structured cancer specific group model that can produce similar 
results to the one-on-one model, we can provide a feasible alternative rehabilitation 
program for cancer survivors. 
Methodology  
Subjects 
Data were obtained from subjects participating in the Phase Training Group 
Model (GM) during the 2016 calendar year.  Participants were both male and female 
cancer survivors who were currently undergoing or had completed cancer treatment 
including surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, 
and/or other types of unconventional treatment.   All participants were eligible for 
participation in the group study if they were cleared to participate in an exercise program 
through a referral by his/her oncologist or primary care physician.  Participants had to be 
able to move freely around the facility with minimal assistance and did not require 
spotting while walking.  Participants that required a walker to move around the facility 
were excluded from the group study.  
Participants were recruited into the group study from referrals by their oncologist 
or primary care physician to participate in an exercise intervention at the University of 
Northern Colorado Cancer Rehabilitation Institute (UNCCRI).  Participants were notified 
about the GM in the initial call from UNCCRI after receiving their referral to schedule an 
initial assessment.  The GM was only offered at certain times during UNCCRI’s daily 
operations, and must have fit within the participants schedule to participate.  Subjects 
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entered into the program with a rolling enrolment, meaning they could start their twelve-
week program once they signed up and did not have to wait for a certain start date. All 
protocols used for the study were approved by the University of Northern Colorado’s 
(UNC) Institutional Review Board (see Appendix A).  All exercise testing and training 
took place at UNCCRI on the University of Northern Colorado campus in Greeley, 
Colorado. 
Patient Screening and Paperwork   
After receiving the participant’s physician referral and signed consent form, each 
subject was asked to complete questionnaires evaluating their psychological function, 
lifestyle, behavior, and medical information.  All questionnaires were completed at the 
subject’s home prior to their initial assessment.  The questionnaires included: Medical 
History, Revised Piper Fatigue Scale, Beck Depression Inventory questionnaire, and 
Ferrans and Powers Quality of Life Index Version III. 
Physiological Assessments 
Prior to the design of the participants’ prescriptive exercise, each participant 
completed an Initial Assessment.  Each assessment measured vitals, body composition, 
cardiovascular endurance, muscular strength, and flexibility and range of motion (ROM).  
Prior to and following the completion of exercise testing, participants’ heart rate (HR), 
oxygen saturation (SpO2), and blood pressure (BP) were assessed via heart rate monitors 
around the chest, pulse oximeter, and sphygmomanometer and stethoscope, respectively.  
Cardiovascular endurance was evaluated using the cancer-specific UNCCRI Treadmill 
Protocol which yields VO2peak values (Shackelford et al., 2015).  Muscular strength was 
assessed via the estimated 1-repetition maximum protocol (EST 1-RM) using the Brzycki 
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equation. This test used Cybex Eagle resistance machines (Cybex Inc., Medway, MA), 
and specifically utilized the following machines: chest press, lat pulldown, seated row, 
shoulder press, leg press, leg curl, and leg extension.  
Exercise Prescription  
Prescriptive exercise took place following the assessment and was created using 
the Client Overview document.  The Client Overview indicated the starting Phase, and 
starting target intensity of both the aerobic and resistance training components of the 
program. The participant screening, which was recorded on the Client Summary, and the 
data collected from each assessment protocol, which was recorded on the Data Collection 
Sheet, were used together to create the prescriptive exercise for each participant.  If the 
subject was currently undergoing chemotherapy and/or radiation therapy, he or she was 
placed in Phase I. If treatment had ended at entry into the program or if the subject 
underwent surgical intervention and/or other treatments (hormonal, immune, etc.), he or 
she was placed in Phase II.  Once a subject had completed Phase II and the reassessment, 
subjects were then moved into Phase III of the Phase Training Model. The assessment 
results and specifically the classifications achieved by the participant during each 
assessment were utilized to begin the process of selecting the appropriate target intensity 
of the intervention.  Table 1 describes the criteria for the entry and transition in the Phase 
Training Model and Phase intensity.   
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Table 1 
 
Phase Transitions and Intensities  
Phase Entry Criteria Intensity 
1 Participants who are still in treatment 30-45% EST 1-RM and 
an RPE of 3-5 
2 Have completed cancer treatment or receiving 
hormonal treatment, or after the completion of 
Phase 1 
40-60% EST 1-RM and 
a RPE of 5-7 
3 By completing Phase 2 60-85% EST 1-RM and 
a RPE of 6-8 
 
Exercise Intervention 
 There was one Cancer Exercise Specialist (CES) working with the group 
throughout its duration, who recorded all physiological data.  The frequency of training 
was prescribed as two sessions per week for twelve weeks.  The duration of each exercise 
session was 60 minutes with 20 minutes designated for cardiovascular exercise, 30 
minutes for resistance exercise, 10 minutes for flexibility training, and with balance 
exercises incorporated throughout the entire session.  The intensity of the prescriptive 
exercise was directly based on the individual’s treatment status, assessment results and 
the starting Phase.  The GM did not use heart rate monitors to record intensity during the 
aerobic session, due to only having one CES accounting for multiple participants.  
Instead, the revised RPE scale (0-10) was used to prescribe intensity for the aerobic 
portion. 
Orientation 
The first two days of the GM, survivors participated in an orientation of their 
exercise program.  Lacking the direct supervision of a CES for each participant, the main 
goal of orientation was to understand the intensity and progression of their intervention as 
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well as the proper use and safety precautions of all equipment being used.  All 
orientations were performed one-on-one with the CES who was overseeing the group.     
Day One Orientation: The first part of orientation reviewed the results of the 
Initial Assessment along with the intensities in which the CES has prescribed for the 
participant.  Following this, each participant underwent an orientation of to the 
cardiovascular equipment.  During this time the participant was shown all the available 
options to perform the cardiovascular aspect of the workout, this included treadmill, 
upright and recumbent bike, and Nustep.  How to properly get on and off the machine, 
changing intensity and how to stop the machine immediately in case of an emergency 
was reviewed.  While on the cardiovascular machine RPE was reviewed in order for 
participants to determine the speed and resistance of the appropriate intensity.   
Day Two Orientation: Consisted of a review of the cardiovascular machine, as 
well as the muscular strength machine orientation.  During the machine orientation 
participants were shown how to properly use each piece of machine along with the proper 
seat position on every machine.  After completion of the two days of orientation, the 
participant began their twelve week intervention   
Statistical Analysis  
 A two related samples Wilcoxon Signed-Rank Test was utilized to examine if 
significant differences occurred in cardiovascular endurance, muscular strength, and 
fatigue.  The following dependent variables were assessed: VO2peak, EST 1-RM leg press, 
EST 1-RM chest press, EST 1-RM seated row, EST 1-RM lat pull down, EST 1-RM 
shoulder press and fatigue.  With the low number of participants, pre and post results of 
all completed phases were compared.  Statistical analyses were performed using the 
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Statistical Package for the Social Science software package (SPSS, Chicago, IL).  
Significance levels were set at p < 0.05.      
Results 
The purpose of this study was to determine if the UNCCRI Phase Program was 
more effective in a group model setting or in a one-on-one setting.  Effectiveness was 
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and 
cancer-related fatigue. Establishing a cancer rehabilitation model that can be 
administrated in an individual and group setting could provide adaptability for clinics and 
hospitals administrating a cancer rehabilitation program. By creating a structured cancer-
specific group model that can produce results similar to the one-on-one model, a feasible 
rehabilitation program for the large number of cancer survivors could be provided.  It was 
hypothesized that the Phase Training Cancer Rehabilitation Program is more effective 
with a one-on-one model when compared to a group model.   
 Table 2 summarizes the demographic characteristics of study participants.  A total 
of 14 cancer survivors were recruited to participate in the group study.  Of the fourteen, 
12 completed the program (seven males and five females).  The treatments the 
participants received prior to or during the program included: surgery only, radiation 
only, combination of surgery and chemotherapy, combination of surgery and radiation, 
and the combination of surgery, radiation, and chemotherapy.  The attendance rate for the 
exercise programs sessions throughout the study was 71%.  After participants completed 
a Phase there was a 75% retention rate for continuing the Phase Training Model GM.  On 
average each participant completed eight strength exercises during each exercise session.  
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This number of completed exercises meets the ACSM recommendations of completing 
eight to ten different exercises within a session. 
Table 2 
 
Participants Characteristics  
 
Changes in Peak Volume of Oxygen  
Consumption, Muscular Strength,  
and Fatigue in Group Model 
 
Table 3 depicts absolute values (pre-to-post) for the GM for VO2peak (mLkg-
1min-1), leg press MS (pounds lifted), chest press MS, seated row MS, shoulder press 
MS, and fatigue.  Figure 1 depicts mean percent change in VO2peak and fatigue.  Figure 2 
Participant Characteristics N=12 
Age (years) 68 ± 12 
Male, n (%) 7 (58) 
Female, n (%) 5 (42) 
Height (Inches) 67 ± 4 
Weight (pounds) 160 ± 19 
Phase N (%) 
Phase 1  2 (17) 
Phase 2  6 (50) 
Phase 3  4 (33) 
Cancer Type N (%) 
Breast 1 (8) 
Prostate 4 (34) 
Colorectal  3 (25) 
Uterine 3 (25) 
Melanoma  1 (8) 
Cancer Stage  N (%) 
I 1 (8) 
II 4 (34) 
III  3 (25) 
IV 3 (25) 
Unknown/not staged  1 (8) 
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depicts pre to post strength differences for lower and upper body, while figure 3 depicts 
mean percent changes in lower body and upper body strength.  
After completing a twelve week intervention in the GM, significant improvements 
(p<0.05) were observed in VO2peak (mLkg-1min-1), leg press MS, chest press MS, seated 
row MS, and shoulder press MS, and fatigue.  Non-significant improvements (p>0.05) 
were observed in lat pull down MS, leg extension MS, and leg curl MS.  Figure 8 depicts 
the percent change for each variable was as follows: VO2peak (9%), leg press MS (10%), 
chest press MS (16%), seated row MS (11%), shoulder press MS (18%) and fatigue        
(-36%).   
Table 3 
 
Improvements in Physiological Values and Fatigue 
Note. N = number of participants, VO2peak = peak volume of oxygen consumption 
(mL·kg-1·min-1); MS = muscular strength (pounds lifted), * denotes a p value < 0.05 
between pre and post values. 
 
 
Group Model         
Strength Variables             N=12    
 Pre  Post  
VO2peak 19.1  ±  4.0  21.1 ±  3.9*  
Leg Press MS 172  ±  66  190 ±  81*  
Leg Curl MS 80 ±  33  85 ±  39  
Leg Extension MS 114 ±  27  131 ± 38  
Chest Press MS 64 ±  33  77 ±  38*  
Seated Row MS 90 ±  33  101 ±  33*  
Lat Pull down MS 108 ±  35  115 ±  35  
Shoulder Press MS 45 ±  16  54 ±  13*  
Fatigue 4.9 ±  1.1  3.1 ±  2.0*  
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Figure 1. Mean percent change in VO2peak and fatigue pre to post each phase transition 
in the GM. *p < 0.05 
 
 
Figure 2. Muscular strength changes with each Phase transition in the GM.   
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Figure 3. Mean percent change in upper and lower body strength between each Phase 
transition; *p < 0.05 
 
Individual vs. Group Phase Training Models 
The twelve participants of the GM completed Phase 1, Phase 2 and Phase 3 of the 
GM.  When comparing the results of the Individual Phase Training Model (IM) to the 
GM we evaluated all of the Phase transitions completed by the participants.  The GM had 
a significantly lower N than the compared IM making the IM results more significant 
than the GM.   Figure 4 depicts the mean percent change in VO2peak and strength between 
the IM compared to the GM.  Figure 5 depicts the mean percent change in fatigue 
between the IM and GM Phase Training Model.  When determining the mean values for 
the IM, the average was determined from the combining the average percentages from 
each phase transition, Phase I to Phase II, Phase II to Phase III, and Phase III to 
completion of the program.       
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Although the GM was a pilot study and had drastically lower number of 
participants, similar results between GM and the IM Phase Training Model were 
observed in all variables.  When observing the changes in fatigue classification, five 
participants stayed within the moderate category although their fatigue score decreases, 
six participants went from moderate to mild, and one participant went from mild to none 
in fatigue classification.  
 
Figure 4. Comparison between the individual and group model in percent change in 
VO2peak and Strength 
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Figure 5. Mean percent change in fatigue between the one-on-one and group model  
Discussion 
 To date, the Phase Training Model introduced by Brown (2016) is the only 
established structured model for cancer rehabilitation that includes mode, intensity, 
frequency and duration for cancer survivors.  The main attributes to the success of the 
Phase Training Model is the cancer specific fitness assessments utilized to create a 
detailed and individualized exercise prescription for each participant.  This study 
indicates that the Phase Training Model can be effectively administered in an individual 
or group model.  The GM produced significant improvements in cardiovascular fitness, 
upper and lower body muscular strength, and fatigue throughout all phases of the 
program.  An important take away from this study is that a group design is safe, effective, 
and well tolerated for all cancer patients regardless of diagnosed cancer stage and 
treatment status.   In this study, six participants were able to complete one or more Phases 
of the group program with cancer stage diagnosis of three or four.  The group model also 
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shows to be well-tolerated for patients who are currently undergoing treatment.  This 
supports Brown (2016) findings that Phase one’s intensity is safe and effective in 
producing significant psychological and physiological improvements, and should become 
the standard intervention for patients undergoing treatment.  This study indicates that 
when using the same assessments and guidelines for exercise prescription as the Phase 
Training Model protocol, it is safe and well tolerated for any cancer patient whether the 
program is administrated individually or in a group.                         
Group vs Individual 
 The GM yielded similar results to the other group studies as well as the IM Phase 
Training Model.  With the small number of participants in the pilot study of the GM, 
Phase-to-Phase transitions could not be compared to the IM Phase Training Model. 
Comparing the IM Phase Training Model to the GM the results are very similar when 
evaluating the overall improvements of the total program.  When comparing the mean 
percent change in VO2peak and strength in participants completing Phase one and two, the 
results are very similar between the participants completing the IM and GM.  Participants 
completing the IM resulted in an average 10.8% increase in VO2peak, while the GM 
resulted in an average 9.4% increase.  Participant’s leg press strength increased by an 
average of 8.9% in the IM compared to an average 10.3% increase in the GM.  
Participant’s chest press strength increased by an average of 15.6% in the IM, in 
comparison to an average 16.5% increase in the GM.   The mean percent change in 
fatigue for participants completing the IM was a 20.7% decrease, while the GM 
experienced a 36% decrease in fatigue.  The only outcome that was lower in the GM than 
the IM was cardiovascular endurance.  The smaller increase in cardiovascular endurance, 
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although still significant, can be attributed to two main disadvantages of the GM.  One 
disadvantage is not having the ability to use heart rate in the participants exercise 
prescription.  The disadvantage of using RPE for the cardiovascular portion of the 
exercise session is that it can change daily within cancer patients depending on the side 
effects cancer treatment toxicities that can have an impact on fatigue, pain, and mental 
state.  The second disadvantage of the GM is the lack of constant encouragement, 
motivation, and supervision of the CES which is provided in the IM.  In some cases the 
prescribed intensity for an individual to reach their target heart rate and RPE can be quite 
challenging.  Without a CES by their side to help push them to the prescribed intensity 
participants have a hard time reaching the prescribed heart rate zone.  Due to this a 
participant suffering from severe cardio toxicities would benefit greater in the IM Phase 
Training Model than the GM.   The greatest difference in the results between the IM and 
the GM was fatigue.  With administrating the same exercise intensity ranges for 
participants in each Phase, the greater decrease in fatigue seen in GM can be attributed to 
working within the group.  Although the GM had a smaller N than the IM compared to, 
the similar results between the IM and the GM, demonstrates how versatile the Phase 
Training Model can be for clinics and hospitals.        
 In recent studies group exercise models have included additional services such as 
support groups or team activities to the exercise program to enhance group cohesion 
(Dittus et al 2015; May et al. 2008, Midtgaard et al 2006).  It has been established that 
group cohesion can produce positive effects on program outcomes (May et al. 2008).  
This is the first study where the group model is only based on exercise prescription and 
does not include any additional services.  Although the study did not include additional 
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services and only focused on exercise, there were still significant improvements seen in 
participant’s psychological factors, such as cancer related fatigue.  This indicates that 
group exercise alone may have a positive effect on the negative psychological effects of 
cancer diagnosis and treatment.  Although there were no additional services offered to the 
participants in the Phase Training Group Model, participants had the opportunity to 
socialize throughout their exercise intervention, where they were able to get to know each 
other and create a sense of group cohesion.  This indicates that group cohesion may not 
need to be administered in additional services but rather having cancer survivors working 
out in the same facility creates a group aspect all on its own.   
 The largest limitation of this study was the number of participants allowing us to 
only present this study as a pilot.  UNCCRI plans to continue this study to collect enough 
data to be able to compare the Phase Training Model side by side to the UNCCRI Group 
Model.  One limitation the GM experienced from the IM was not being able to use heart 
rate percentages in the exercise prescription.  Without the use of heart rate monitors 
participants were asked to exercise at a prescribed RPE.  This type of prescription is less 
accurate than heart rate because RPE can differ greatly in cancer survivors on a day-to-
day basis.  This difference in prescription could be the primary reason the IM resulted in 
better cardiovascular endurance results than the GM.          
The largest barriers for cancer patients to receive rehabilitation through exercise 
interventions are the cost and the lack of exercise facilities tailored to the cancer 
population (Blaney et al. 2010).  With patients unable to receive re-imbursement from 
insurance, the financial burden is put on the cancer survivor needing these services.  
Research has indicated that exercise can have powerful effects on decreasing the negative 
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side effects experienced after and during cancer treatment.  By establishing a group 
exercise rehabilitation program created specifically for cancer patients during any aspect 
of the survivor continuum, more cancer patients can have access to a valuable one-
dimensional rehabilitation program through exercise interventions without the financial 
burden. By demonstrating the Phase Training Model protocol can be safe and effective 
within a GM, it should be established as the standard rehabilitation program for cancer 
patients within the hospital and clinical setting.   
Conclusion 
 To date, the Cancer Phase Training Model is the only cancer rehabilitation 
intervention that includes recommended modes, intensity, frequency, and duration of 
exercise for cancer survivors.  Through the precise cancer-specific pretreatment 
screening, baseline fitness assessment, and individualize exercise prescription, the Cancer 
Phase Training Model has been shown to attenuate the negative physiological and 
psychological effects of cancer treatment.  This pilot study indicates that the Phase 
Training Model protocol can be safely and effectively administrated in a group model.  
Through administrating the Phase Training Program in a group model, professionals can 
have a greater impact by providing services to more cancer survivors without placing the 
financial burden on the survivor or the program provider. By demonstrating its diversity, 
the Phase Training Model should be considered as a standard of care in the clinical 
cancer rehabilitation setting considering its success in both the group and individual 
model.            
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